Neuroendocrine tumors (NET) are frequently diagnosed late and not amenable to curative
surgery due to metastatic disease to the liver and lymph nodes. The disease is complex and …

Introduction: Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are unique and
complex neoplasms, exhibiting a wide spectrum of diverse clinical behaviors. The …

Although neuroendocrine tumors (NET) are a relatively rare malignancy, the reported
incidence is increasing, and some of the current treatment options are limited in their …

Neuroendocrine tumors (NETs) are a group of tumors originating in various locations,
including the gastrointestinal tract, lung, and pancreas. Clinical trial design and disease …

Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse
neuroendocrine system. They frequently originate in the gastroenteropancreatic (GEP) tract …

Background Treatment options for metastatic gastroenteropancreatic neuroendocrine
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare and heterogeneous
class of neoplasms. While surgical resection is the mainstay of treatment, non-surgical …

Neuroendocrine (NE) gastroenteropancreatic tumors are a heterogeneous group of
neoplasias arising from neuroendocrine cells of the embryological gut. Their incidence have …

Treatment of the clinically and prognostically heterogeneous neuroendocrine neoplasms
(NEN) should be based on a multidisciplinary approach, including surgical, interventional …

Neuroendocrine tumors (NET) encompass a heterogeneous group of tumors demonstrating
varied clinical behavior. The field has recently witnessed several important developments …